Navigation Links
Deloitte Stakes Claim in Drug Safety & Regulatory Consulting Market With Acquisition of Intrasphere Technologies, Inc. Assets
Date:8/15/2011

NEW YORK, Aug. 15, 2011 /PRNewswire/ -- Blending the strengths of its world-class life sciences and research and development practice with a market leader in drug safety consulting, Deloitte today announced it has acquired substantially all of the assets of Intrasphere Technologies, Inc. (Intrasphere), a global drug safety and regulatory consulting business.  Terms of the deal were not disclosed.

Headquartered in Jersey City, New Jersey, with its European headquarters in London, Intrasphere provides professional services to help life sciences companies improve product safety, signal intelligence, pharmacovigilance and regulatory information management capabilities.

The acquired assets include Intrasphere's PharmaCM®, a software solution that enables life sciences companies to register clinical trial information on government-mandated registries through the use of workflow-enabled functionality that allows for simplified content management and re-use. The PharmaCM® product will be provided as a service offering within Deloitte Managed Analytics, which is led by Richard Cohen, principal, Deloitte Consulting LLP.

The combined capabilities span a broad spectrum of business and technology solutions in the drug safety market. These solutions focus on enabling enhanced signal intelligence and analytics through the planning, design and implementation of drug safety data warehouses, adverse event management applications, remote data capture tools, and assembly of periodic reporting for regulatory agencies. As a result, this new business will tap into Deloitte's enterprise risk, security and regulatory compliance services, and additional business advisory services.

"We are excited about this important and strategic investment," said Dan Ressler, principal, Deloitte Consulting LLP, who will lead Deloitte's new drug safety and regulatory consulting business as part of his overall responsibilities in leading research and development informatics in life sciences. "The growing impact of health information technology and social media, greater complexity of therapeutic offerings in the marketplace, and an increasingly complex and stringent regulatory environment, in particular, have created an impetus for more proactive product safety and regulatory support services."

Ressler added, "The addition of Intrasphere's capabilities to the Deloitte portfolio of life sciences consulting services enhances our position in drug safety and regulatory consulting and expands the foundation on which we will continue to lead this market. Intrasphere brings deep proficiencies in drug safety, pharmacovigilance and regulatory capabilities to complement our existing life sciences and research and development practice enabling us to expand our ability to create market-leading strategic solutions for our clients."

Intrasphere's existing clientele have the potential to benefit significantly from the transaction. Deloitte's life sciences consulting practice features a broad suite of services ranging from strategy to execution across the life sciences value chain and global reach through the member firms of Deloitte Touche Tohmatsu Limited.

"Deloitte's broad-based relationships in life sciences give us access to clients where we don't have a presence today. Moreover, our staff and leadership now have the opportunity to gain exposure to a variety of resources and opportunities as part of Deloitte," said Bill Karl, co-founder and former chief executive officer of Intrasphere. Karl now joins Deloitte Consulting LLP as a director.

For more information about Deloitte's Life Sciences and Research & Development practice, please go to: http://www.deloitte.com/view/en_US/us/Industries/life-sciences/index.htm

As used in this document, "Deloitte" means Deloitte LLP and its subsidiaries. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.  Certain services may not be available to attest clients under the rules and regulations of public accounting.

Contact:
Daniel Mucisko
Public Relations
Deloitte
+1 973-602-4126
dmucisko@deloitte.com


'/>"/>
SOURCE Deloitte LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Medical Technologies Announces its Subsidiaries, GP Medical and Beijing Yuande, Ranked 12th and 415th, respectively, in Deloitte Technology Fast 500 Asia Pacific 2010 Program
2. New Deloitte Recap Report Identifies Strategies to Help Reduce Development Times and Increase Success Rates for Cancer Drugs
3. DUSA Pharmaceuticals Named to Deloittes 2010 Technology Fast 500 List of Fastest Growing Companies in North America
4. Virtual Radiologic Ranked 264th Fastest-Growing Company in North America on Deloittes 2010 Technology Fast 500™
5. China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program
6. Accuray Ranked Number 113 Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500™
7. Genoptix Ranked 41st Fastest-Growing Company in North America on Deloittes 2010 Technology Fast 500™
8. Deloitte Issue Brief: Mobile Personal Health Records May Offer Consumers Key to Technology-Enabled Self-Care
9. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
10. Time to Blow Up the Pharmaceutical Sales Model? New Deloitte Debate
11. Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... number of ,world firsts,: , TwinLink™ - ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):